GALVmed Newsletter November 2010

GALVmed is a not-for-profit global alliance of public, private and government partners. By making livestock vaccines, diagnostics and medicines accessible and affordable to the millions for whom lives tock is a lifeline GALVmed is protecting livestock and saving human life. It is currently funded by the Bill & Melinda Gates Foundation, the UK’s Department for International Development and the European Union. 

GALVmed is initially focusing on four priority diseases: East Coast fever (which affects cattle), Rift Valley fever (cattle, sheep, goats, camels and also people), porcine cysticercosis (pigs and also people) and Newcastle disease (poultry). This issue has a special focus on East Coast fever – a disease transmitted by ticks that kills an estimated one million cattle in Africa each year. 

In this issue: 

GALVmed and East Coast fever GALVmed outlines its plan to make the East Coast fever Infection and Treatment Method vaccine (ECF-ITM) accessible and affordable to millions of livestock keepers in at-risk countries. 

Capacity building and support to African Union-Centre for Ticks and Tick-Borne Diseases, Malawi 

In 2009, GALVmed selected the AU-CTTBD, based in Lilongwe, Malawi, to become the commercial manufacturer of the ECF-ITM vaccine. Since then a broad range of capacity building measures have been taken and more are planned to enable the Centre to manufacture and supply a quality-assured product throughout the region in a sustainable manner. 

VACNADA - Vaccines for the Control of Neglected Animal Disease of Africa 

Under this EU-funded project, GALVmed is busy moving ahead on a number of fronts to improve the quality and quantity of vaccines produced by eight African laboratories against four key neglected diseases, each of which have major economic and social impacts: CBPP, CCPP, PPR and Newcastle disease. 

Annual visit to the Bill & Melinda Gates Foundation 

GALVmed’s annual visit to the BMGF in Seattle to report and discuss progress on the grant took place in early November. 

Hameed Nuru and Karim Tounkara welcome 300African livestock specialists to ‘meet GALVmed’ 

Dr Hameed Nuru, GALVmed’s Senior Director, Policy and External Affairs, and Karim Tounkara, GALVmed board member and Director of the African Union-Pan African Veterinary Vaccine Center (PANVAC), recently took part in a special TV-style ‘meet GALVmed’ event at the 5th All Africa Conference on Animal Agriculture. 

Team changes 

Introducing new members of GALVmed’s team, including two new board members, and announcing the members of the Global Access Advisory Committee and Regional Advisory Committee (South Asia). 

GALVmed calendar 

Keeping you abreast of what’s coming up over the next few months. 

Jolly good fellows 

Since 2003, around 200 Pfizer Global Health Fellows have spent up to six months working with NGOs spread across 38 countries. GALVmed has been fortunate enough to have benefited from three fellows so far. 

The GALVmed team – under the microscope 

Members of the GALVmed team talk about their role in the organization and also tell us a little about themselves. 

Lastword 

And finally, Steve Sloan, GALVmed CEO, always get the last word...

Year: 
2010